Cheil Bio Co

Cheil Bio Co FCF Conversion

Delisted·Feb 25, 2026

The FCF Conversion Rate (FCF/EBITDA) of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 120.80 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 296.43 % — a change of -59.25% (lower).

FCF Conversion

120.80 %

YoY

-59.25%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Cheil Bio Co is 2024 120.80 % . FCF Conversion Rate (FCF/EBITDA) of Cheil Bio Co was 2023 296.43 % . It decreases by -59.25% lower compared to the previous year.

The Cheil Bio Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
393.56 KRW
Jan 1, 2018
-359.59 KRW
Jan 1, 2019
244.96 KRW
Jan 1, 2020
-326.38 KRW
Jan 1, 2021
23.65 KRW
Jan 1, 2022
-451.86 KRW
Jan 1, 2023
296.43 KRW
Jan 1, 2024
120.80 KRW
The Cheil Bio Co FCF Conversion history
YEARFCF ConversionYoY
120.80 %-59.25%
296.43 %-165.60%
-451.86 %-2,010.53%
23.65 %-107.25%
-326.38 %-233.24%
244.96 %-168.12%
-359.59 %-191.37%
393.56 %+1,885.17%
19.83 %-121.75%
-91.15 %-11.72%
-103.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

FCF Conversion Rate (FCF/EBITDA) of Cheil Bio Co is 120.80 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Cheil Bio Co changed from 296.43 % to 120.80 %, representing a -59.25% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cheil Bio Co

All Key Metrics — Cheil Bio Co